Anzeige
Mehr »
Dienstag, 02.06.2026 - Börsentäglich über 12.000 News
Entsteht hier die nächste Quantum-Story?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W1LG | ISIN: IL0011224156 | Ticker-Symbol:
NASDAQ
02.06.26 | 15:57
0,161 US-Dollar
-19,94 % -0,040
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICECURE MEDICAL LTD Chart 1 Jahr
5-Tage-Chart
ICECURE MEDICAL LTD 5-Tage-Chart

Aktuelle News zur ICECURE MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:54IceCure Medical to boost share price with 1-for-30 reverse split to regain Nasdaq compliance1
ICECURE MEDICAL Aktie jetzt für 0€ handeln
14:45IceCure Medical Ltd. - 6-K, Report of foreign issuer1
14:30IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance44Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Strategy CAESAREA, ISRAEL, June 2, 2026 /PRNewswire/ -- IceCure Medical...
► Artikel lesen
19.05.IceCure Medical: IceCure's ProSense Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked155At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors =3 cm and...
► Artikel lesen
13.05.IceCure Medical Ltd. - 6-K, Report of foreign issuer1
13.05.IceCure Medical: IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement238No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares CAESAREA, Israel, May 13, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM)...
► Artikel lesen
12.05.IceCure Medical GAAP EPS of $0.06, revenue of $911M3
12.05.IceCure Medical Ltd Q1 Sales Increase1
12.05.IceCure Medical: IceCure Reports First Quarter 2026 Financial Results: ProSense Sales Increase Substantially in the U.S. and North America307Pent-up demand immediately following FDA clearance generates 46% increase in active customer accounts using ProSense® as of the end of the first quarter 2026, compared...
► Artikel lesen
10.05.Quant snapshot: Beachbody, Deutsche Telekom among top-rated names as IceCure Medical, Fold Holdings lag31
06.05.IceCure Medical Ltd. - 6-K, Report of foreign issuer-
21.04.IceCure Medical Ltd. - 6-K, Report of foreign issuer-
01.04.IceCure Medical Ltd. - F-1, Registration statement for certain foreign private issuers-
26.03.IceCure prices $4M direct offering, concurrent private placement2
25.03.IceCure Medical Reports Positive Trial Results For ProSense Cryoablation System2
24.03.IceCure Medical: IceCure Appoints Meir Peleg as Chief Financial Officer199Meir Peleg brings over 20 years of financial leadership and experience including with Nasdaq listed companiesIceCure intends to appoint Dr. Richard Fine as Medical Director CAESAREA, Israel...
► Artikel lesen
24.03.IceCure Medical Appoints Meir Peleg As CFO; Shares Rise In Pre-market-
24.03.IceCure Medical Ltd. - 6-K, Report of foreign issuer1
17.03.IceCure Medical: IceCure Reports 2025 Full Year Financial & Operational Results403Record 4th quarter and full year sales of $1.3 million and $3.4 million, respectively Strong commercial momentum for ProSense® in the U.S. and globally following...
► Artikel lesen
17.03.IceCure Medical Ltd Profit Drops In Full Year-
Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1